SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
INCYTE
(NQNM:INCY Last Sale: 100.99 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (INCY : $100.99)
$21,909,976 million Market Cap at Market Close, July 1, 2022
Employs 175.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
Experimental Station Route 141 Research Report Earnings Snapshot - Last 10/30/18
Henry Clay Road Building E 336 Fact Sheet
Wilmington, DE 19880 Financial Statements
Phone: 302-498-6700 Peer Comparison
Annual Reports

Paul A. Friedman, CEO/Pres., David C. Hastings, CFO
Formerly INCYTE GENOMICS INC and INCYTE PHARMACEUTICALS INC (NASDAQ:INCY). Designs, develops, markets and supports genomic database products and services using computer-aided gene sequencing. Secondary sold 9 million shares at $9.75 November 1, 2004.
Historical Charts    Technical Analysis
No Historical Data available for INCY

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common INCY $100.99 $100.99 0 .0 $97.71 $101.38 1,469,362 $97.71 $101.38 216,951,933
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock #############

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
31-AUG-00 INCY Split 2 for 1
07-NOV-97 INCY Split 2 for 1

A905
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex